Your search has returned 63 results
recall
Alert: Altaire Pharmaceuticals, Inc. recalls Perrigo brand ophthalmic products
Concerns about quality assurance controls
recall
Alert: American Health Packaging Valsartan Tablets, USP, 160 mg
Presence of probable human carcinogen N-Nitrosodiethylamine
recall
Alert: Amlodipine and Valsartan Tablets, USP; Valsartan Tablets, USP; and Valsartan and Hydrochlorothiazide Tablets, USP
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP
Presence of probable human carcinogen N-nitrosodiethylamine
recall
Alert: Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets
Presence above specification limits of probable carcinogen N-nitroso-diethylamine
recall
Alert: Aurobindo Pharma mirtazapine tablets
Aurobindo Pharma USA, Inc. recalls mirtazapine tablets due to a label error on declared strength.
recall
Alert: Aurobindo Pharma/ScieGen Pharmaceuticals Irbesartan
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: AurobindoPharma Acetris Valsartan Tablets, USP
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: AurobindoPharma Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP (Expanded Recall)
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: B. Braun Medical Inc. blood administration sets
B. Braun Medical Inc. blood administration sets recalled due to potential leakage at joint between blood filter and tubing.
recall
Alert: BD CareFusion 303, Inc. Alaris Pump Module Model 8100 Bezel Assembly
The bezel posts may become cracked and separated which could lead to inaccurate delivery of fluids to the patient.
recall
Alert: Camber Pharmaceuticals Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg
Presence of potential carcinogen N-Nitroso N-Methyl 4-amino butyric acid
recall
Alert: Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g
Presence of visual grey particulate matter in reconstituted vials
recall
Alert: Dechra Veterinary Products ophthalmic products recalled by Altaire Pharmaceuticals
Concerns about quality assurance controls
recall
Alert: Dyural-40 and Dyural-80 Convenience Kits
Product labeling incorrectly stating stoppers do not contain latex.
recall
Alert: ECHELON FLEX™ ENDOPATH® staplers
Echelon Flex Endopath staplers recalled for failure to completely form staples.
recall
Alert: Edwards Lifesciences Swan-Ganz Thermodilution Catheter
Incorrect assembly causing reversal of lumens
recall
Alert: FDA alert: Compounded drug product containing pyrimethamine and toltrazuril
Adverse events leading to the deaths of at least three horses
recall
Alert: Fentanyl Transdermal System
Product mislabeling; cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches
recall
Alert: Golden State Medical Supply Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Hospira, Inc. 8.4% Sodium Bicarbonate Injection, USP
Presence of particulate matter, confirmed as glass
recall
Alert: Hospira, Inc. recalls BACTERIOSTATIC WATER for Injection, USP, 30 mL
Potential lack of sterility assurance
